BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,050 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $239,838 | -34.2% | 6,305 | -20.6% | 0.03% | -32.6% |
Q2 2023 | $364,433 | -28.1% | 7,940 | -36.0% | 0.04% | -34.8% |
Q1 2023 | $507,208 | -38.8% | 12,412 | -23.3% | 0.07% | -41.6% |
Q4 2022 | $829,310 | -11.2% | 16,177 | -6.2% | 0.11% | -15.7% |
Q3 2022 | $934,000 | -16.4% | 17,252 | -0.4% | 0.13% | -14.1% |
Q2 2022 | $1,117,000 | -18.7% | 17,317 | -2.2% | 0.16% | -3.1% |
Q1 2022 | $1,374,000 | -9.7% | 17,715 | 0.0% | 0.16% | -4.7% |
Q4 2021 | $1,521,000 | +5.9% | 17,715 | -0.8% | 0.17% | -3.4% |
Q3 2021 | $1,436,000 | -3.3% | 17,850 | -3.2% | 0.18% | -6.4% |
Q2 2021 | $1,485,000 | -5.0% | 18,449 | -0.4% | 0.19% | -13.8% |
Q1 2021 | $1,563,000 | +3.6% | 18,529 | -1.4% | 0.22% | 0.0% |
Q4 2020 | $1,508,000 | -0.3% | 18,799 | -0.1% | 0.22% | -11.1% |
Q3 2020 | $1,513,000 | -9.3% | 18,819 | -2.9% | 0.24% | -17.3% |
Q2 2020 | $1,668,000 | +3.9% | 19,374 | -2.0% | 0.30% | -16.0% |
Q1 2020 | $1,605,000 | -9.2% | 19,774 | -6.5% | 0.35% | +3.8% |
Q4 2019 | $1,768,000 | -5.3% | 21,139 | -0.9% | 0.34% | -15.1% |
Q3 2019 | $1,866,000 | -12.0% | 21,335 | -17.6% | 0.40% | -5.9% |
Q2 2019 | $2,121,000 | -1.0% | 25,900 | -1.7% | 0.42% | -3.4% |
Q1 2019 | $2,143,000 | +21.3% | 26,350 | -1.8% | 0.44% | +4.8% |
Q4 2018 | $1,767,000 | -15.7% | 26,845 | -1.3% | 0.42% | -2.8% |
Q3 2018 | $2,096,000 | +4.2% | 27,195 | -0.2% | 0.43% | -8.3% |
Q2 2018 | $2,012,000 | +12.8% | 27,245 | -0.6% | 0.47% | +10.9% |
Q1 2018 | $1,783,000 | -0.3% | 27,410 | -0.9% | 0.42% | -2.1% |
Q4 2017 | $1,788,000 | +2.9% | 27,656 | -0.1% | 0.43% | -6.3% |
Q3 2017 | $1,738,000 | +3.5% | 27,696 | -0.2% | 0.46% | -2.5% |
Q2 2017 | $1,680,000 | +7.3% | 27,746 | -8.0% | 0.47% | +2.4% |
Q1 2017 | $1,565,000 | +16.2% | 30,171 | -0.7% | 0.46% | +7.7% |
Q4 2016 | $1,347,000 | -8.1% | 30,381 | -1.3% | 0.43% | -11.7% |
Q3 2016 | $1,466,000 | +4.8% | 30,791 | -0.5% | 0.49% | +5.2% |
Q2 2016 | $1,399,000 | +9.3% | 30,941 | -0.8% | 0.46% | +4.3% |
Q1 2016 | $1,280,000 | +6.5% | 31,181 | -1.1% | 0.44% | +4.2% |
Q4 2015 | $1,202,000 | – | 31,531 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |